Product News
Laverock Therapeutics Secures Innovate UK Award To Advance Immune Effector Cell Therapeutics Programme
Laverock Therapeutics secures £1m funding via the Innovate UK Investor Partnerships Future Economy programme, supported by UKI2S.
Product News
Cytiva and RoosterBio Collaborate To Address Exosome Manufacturing Challenges
Aiming to improve exosome purification process that is currently slowing adoption of promising gene therapies and other new modalities.
Product News
Integrated DNA Technologies Opens New Therapeutic Manufacturing Facility
Expanded footprint, new capabilities mark IDT’s entrance into CRISPR therapeutics space.
Product News
New Mid-Term Guidance 2024 – 2028 Supported by Ramp-Up of Growth Projects
At its Capital Markets Day in Visp (CH), Lonza shared a detailed update on its strategic priorities and provided new Mid-Term Guidance for 2024 to 2028.
Product News
Lonza Announces New Filling Line for Commercial Supply of Antibody-Drug Conjugates for a Dedicated Customer
Lonza, announced the extension of a collaboration with a major biopharmaceutical partner for the commercial-scale filling of ADCs.
Product News
Gates Foundation To Accelerate mRNA Vaccine Innovation and Manufacturing in Africa and Globally
At the 2023 Grand Challenges Annual Meeting, Bill Gates, announced new investments to advance access to mRNA research and vaccine manufacturing technology that will support low- and middle-income countries.
Product News
Takara Bio enters into a license agreement of RetroNectin® with Fondazione Telethon ETS
Takara Bio Inc. announces that it has entered into a License Agreement with non-profit/charity organization, Fondazione Telethon ETS Italy, under which Takara Bio grants Telethon a commercial license to use RetroNectin®.
Product News
Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing
Sino Biological, Inc. is pleased to announce the formal opening of its new Center for Bioprocessing (C4B) in Houston, Texas USA at Levit Green, adjacent to the world-renowned Texas Medical Center.
Product News
Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Use in Preclinical and Clinical Drug Development
Range of highly selective anti-idiotypic antibodies now includes six antibodies specific to dupilumab and its biosimilars for bioanalysis and Drug Monitoring.
Product News
Lonza Further Extends Collaboration With Major Biopharmaceutical Partner for Manufacturing Antibody-Drug Conjugates
Extended long-term collaboration to provide significant additional bioconjugation capacity for commercialization of antibody-drug conjugates (ADCs) for use against hard-to-treat cancers.
Advertisement